2000
DOI: 10.1097/00132586-200002000-00041
|View full text |Cite
|
Sign up to set email alerts
|

Management of Opioid-Induced Pruritus: A Role for 5-HT3 Antagonists?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
31
0

Year Published

2003
2003
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(31 citation statements)
references
References 0 publications
0
31
0
Order By: Relevance
“…Although most pruritus symptoms in this study were relieved by antihistamines, histamine is not released in intrathecal opioid-induced pruritus and does not appear to be causative. (19,20) Therefore, symptom relief may have been associated with the sedative properties of antihistamines rather than actual relief of the itching sensation. Moreover, antihistamines may enhance the sedative effects of opioids, which could be dangerous when intrathecal opioid is involved.…”
Section: Discussionmentioning
confidence: 99%
“…Although most pruritus symptoms in this study were relieved by antihistamines, histamine is not released in intrathecal opioid-induced pruritus and does not appear to be causative. (19,20) Therefore, symptom relief may have been associated with the sedative properties of antihistamines rather than actual relief of the itching sensation. Moreover, antihistamines may enhance the sedative effects of opioids, which could be dangerous when intrathecal opioid is involved.…”
Section: Discussionmentioning
confidence: 99%
“…One goal of the present study was therefore to investigate which 5-HT receptor subtypes are involved in acute scratching elicited by intradermal 5-HT in the rat. Although 5-HT 3 receptors have been implicated in itch associated with cholestasis, uremia, and spinal opioids (Schworer et al, 1995;Balaskas et al, 1998;Kyriakides et al, 1999), 5-HT 3 receptor antagonists did not affect scratching elicited by intradermal 5-HT in mice, in contrast to the blockade of scratching by 5-HT 2 antagonists (Yamaguchi et al, 1999). These data argue against a role for 5-HT 3 receptors in acute evoked scratching in mice.…”
mentioning
confidence: 86%
“…Opioids also act in areas of the brain (probably medulla oblongata) to cause itching [8]. Neuraxial opioids can also itching by acting on serotonin (5-hydroxytryptamine) Type III receptors in the dorsal part of spinal cord and the nucleus of the spinal tract of the trigeminal nerve in the medulla [9,10].…”
Section: Discussionmentioning
confidence: 99%